Latest News

Priority Review to Head and Neck Cancer Drug in Top Oncology News
Recent advances and updates in oncology and cancer drug development.
Synjardy expanded to include treatment naïve adults with type 2 diabetes.
Optimal channel selection should be made with the patient’s best interest at the center of the decision.
New initiative supports several research collaborations to find a cure for HIV/AIDS.
Top news of the day from across the health care landscape.
Surveys show patients more willing to seek more aggressive treatment than physicians realize.
An award of $55 million will help launch different infrastructure needed to improve precision medicine.
Study sheds light on HIV development.


Challenges Continue for True Patient-Centered Access
Access to oral chemotherapies is filled with challenges for providers and patients that can be significant, resulting in delayed therapy.
As with care for any chronic condition, the goals for advanced oncology therapies should be improving outcomes, containing costs, and increasing medication adherence.
As new biosimilars enter the market, pharmacies should carefully consider infrastructure, resources, and strategies for successfully integrating the products into their portfolio of offerings.
Despite initiatives that help patients maintain adherence, health care providers still need to leverage their collective resources and work together to overcome this tremendous hurdle in cancer care.

Featured Company Profile

MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy


Josh Stein, CEO and co-founder of AdhereTech, discusses how technology can enhance the ability of specialty pharmacies to manage their patients' therapy regimen.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses the cost implications of pricey cholesterol-lowering PCSK9 inhibitors.

Rinku A. Patel, PharmD, RPh, founder and CEO of KloudScript, discusses the optimal use of technology and data to improve patient care in specialty pharmacies.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of the CSI Specialty Group, discusses improved communication among specialty drug manufacturers and health care providers.

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2016
Intellisphere, LLC. All Rights Reserved.